Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 8-K Event Executive or director change
  4. 4 Shares withheld for taxes President & CEO gave up 2,205 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Legal Officer gave up 661 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 661 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief People Officer gave up 661 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Scientific Officer gave up 661 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Business Officer gave up 661 shares (to pay taxes)
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. SC 13G Stake Amended Statement of Ownership
  13. 4 Grant or award Chief Medical Officer acquired 61,300 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 4 Grant or award Director acquired 3,976 shares (grant or award)
  17. 4 Grant or award Director acquired 3,887 shares (grant or award)
  18. 4 Grant or award Director acquired 4,858 shares (grant or award)
  19. 8-K Event Executive or director change · Shareholder vote results
  20. 4 Derivatives Options or other derivatives

Page 14 of 28 · 549 filings